Role of replicative senescence in the progression of fibrosis in hepatitis C virus (HCV) recurrence after liver transplantation

Transplantation

Volumn 77, Issue 11, 2004, Pages 1755-1760

  Trak Smayra, Viviane ^a   Contreras, Jorge ^a   Dondero, Federica ^a   Durand, François ^a   Dubois, Sylvie ^a   Sommacale, Daniel ^a   Marcellin, Patrick ^a   Belghiti, Jacques ^a   Degott, Claude ^a   Paradis, Valérie ^a,b  

^a BEAUJON HOSPITAL   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CORTICOSTEROID; CYCLOSPORIN; LYMPHOCYTE ANTIBODY; TACROLIMUS;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER ISCHEMIA; LIVER NECROSIS; LIVER TRANSPLANTATION; LONG TERM CARE; LONGITUDINAL STUDY; MALE; METAVIR SCORE; PRIORITY JOURNAL; RECURRENT DISEASE; REPLICATIVE SENESCENCE; REVASCULARIZATION; SCORING SYSTEM; SENESCENCE; VIRUS INFECTION;

ADULT; BETA-GALACTOSIDASE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; ISCHEMIA; LIVER; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NECROSIS; NEUTROPHIL INFILTRATION; POSTOPERATIVE COMPLICATIONS; RECURRENCE; TIME FACTORS; VIRUS REPLICATION;

EID: 2942644356     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000131172.75294.A9     Document Type: Article

References (26)

1. Wright T, Donegan E, Hsu H, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103: 317.
2. Feray C, Gigou M, Samuel D, et al. The course of hepatitis C infection after liver transplantation. Hepatology 1994; 20: 1137.
3. Gane E, Portmann B, Naoumov N, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815.
4. Berenguer M, Lopez-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol 2001; 35: 666.
5. Di Bisceglie A, Goodman ZD, Ishak KG. Long-term clinical, and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991; 14: 969.
6. Poynard T, Bedossa P, Opolon P, for the OBSVIRC, METAVIR, CLINVIR, and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825.
7. Pol S, Fontaine H, Carnot F, et al. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients. J Hepatol 1998; 29: 12.
8. Garcia-Samaniego J, Soriano V, Castilla J, et al. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The hepatitis/HIV Spanish Study Group. Am J Gastroenterol 1997; 92: 1130.
9. Berenguer M, Crippin J, Gish R, et al. A model to predict severe HCV-related disease following liver transplantation. Hepatology 2003; 38: 34.
10. Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci U S A 1995; 92: 11190.
11. Goldstein S, Moerman Ej, Soeldner JS, et al. Diabetes mellitus and genetic prediabetes: Decreased replicative capacity of cultures skin fibroblasts. J Clin Invest 1979; 63: 358.
12. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999; 10: 167.
13. Kitada T, Seki S, Kawakita N, et al. Telomere shortening in chronic liver disease. Biochem Biophys Res Commun 1995; 211: 33.
14. Paradis V, Youssef N, Dargere D, et al. Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinoma. Hum Pathol 2001; 32: 327.
15. Lunz JG, Contrucci S, Ruppert K, et al. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection. Am J Pathol 2001; 158: 1379.
16. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458.
17. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 1992; 89: 10114.
18. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995; 92: 9363.
19. Ferlicot S, Durrbach A, Bâ N, et al. The role of replicative senescence in chronic allograft nephropathy. Human Pathol 2003; 34: 924.
20. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658.
21. The METAVIR cooperative group. Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C. Hepatology 1994; 20: 15.
22. Feray C, Caccamo L, Alexander GJ, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. Gastroenterology 1999; 117: 619.
23. Ghobrial RM, Steadman R, Gornbein J, et al. A 10-year experience of liver transplantation for hepatitis C: Analysis of factors determining outcome in over 500 patients. Ann Surg 2001; 234: 384.
24. Chopra KB, Demetris AJ, Blakolmer K, et al. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation. Transplantation 2003; 76: 1487.
25. Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science 1996; 273: 59.
26. Dumont P, Burton M, Chen QM, et al. Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblasts. Free Rad Biol Med 2000; 28: 361.